NYXOAH SA - ORDINARY S

Conditional Issuance of Shares

16 Apr 2025 02:00:00 By Nasdaq GlobeNewswire

Nyxoah Provides Update on FDA Approvable Letter for Genio System

08 Apr 2025 01:00:00 By Nasdaq GlobeNewswire

FDA Issues Nyxoah an Approvable Letter for its Genio® System

26 Mar 2025 03:00:00 By Nasdaq GlobeNewswire

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

13 Mar 2025 02:00:00 By Nasdaq GlobeNewswire

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

10 Mar 2025 17:05:00 By Nasdaq GlobeNewswire

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

03 Mar 2025 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

19 Feb 2025 01:05:00 By Nasdaq GlobeNewswire

Publication relating to transparency notifications

20 Jan 2025 16:30:00 By Nasdaq GlobeNewswire

Publication relating to transparency notifications

20 Dec 2024 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

13 Dec 2024 02:05:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

27 Nov 2024 16:30:00 By Nasdaq GlobeNewswire

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024

19 Nov 2024 01:00:00 By Nasdaq GlobeNewswire

Publication relating to transparency notifications

18 Nov 2024 16:30:00 By Nasdaq GlobeNewswire

Nyxoah Reports Third Quarter Financial and Operating Results

06 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Nyxoah Appoints John Landry as Chief Financial Officer

04 Nov 2024 16:45:00 By Nasdaq GlobeNewswire

Publication relating to transparency notifications

25 Oct 2024 16:30:00 By Nasdaq GlobeNewswire

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

22 Oct 2024 16:30:00 By Nasdaq GlobeNewswire

Publication relating to transparency notifications

15 Oct 2024 16:30:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

09 Oct 2024 16:35:00 By Nasdaq GlobeNewswire